Studies

  1. Low-Fat, High-Fiber Diet Reduces Markers of Inflammation and Dysbiosis and Improves Quality of Life in UC

  2. Discontinuation of infliximab in patients with ulcerative colitis in remission (HAYABUSA): a multicentre, open-label, randomised controlled trial

  3. Etrolizumab vs infliximab in UC

  4. Adalimumab in paediatric UC

  5. Exclusive enteral nutrition in ASUC

  6. Mediterranean diet or Simple Carbohydrate Diet in CD

  7. 5-Hydroxytryptophan on fatigue in quiescent IBD